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http://dx.doi.org/10.1016/j.ccr.2014.05.015SUMMARYIn selective autophagy, receptors are central for cargo selection and delivery. However, it remains yet unclear
whether and how multiple autophagy receptors might form complex and function concertedly to control
autophagy. Optineurin (OPTN), implicated genetically in glaucoma and amyotrophic lateral sclerosis, was
a recently identified autophagy receptor. Here we report that tumor-suppressor HACE1, a ubiquitin ligase,
ubiquitylates OPTN and promotes its interaction with p62/SQSTM1 to form the autophagy receptor complex,
thus accelerating autophagic flux. Interestingly, the Lys48-linked polyubiquitin chains that HACE1 conju-
gates onto OPTN might predominantly target OPTN for autophagic degradation. By demonstrating that
the HACE1-OPTN axis synergistically suppresses growth and tumorigenicity of lung cancer cells, our findings
may open an avenue for developing autophagy-targeted therapeutic intervention into cancer.INTRODUCTION
Macroautophagy (hereafter referred to as autophagy) is an
evolutionarily conserved process that cells use to deliver cyto-
solic proteins to the lysosome for degradation (Klionsky et al.,
2012; Ohsumi, 2014). Although autophagy has generally beenSignificance
Receptors are central for cargo selection and delivery during s
nized in vivo is as yet unknown. In this article, we report that tum
receptors Optineurin (OPTN), which promotes the formation
SQSTM1, and activates autophagy. This suggests an underapp
Because HACE1 is frequently downregulated or mutated in hum
is known to affect tumorigenesis and tumor drug responses, t
ising strategy for cancer therapy.
106 Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc.thought to be nonselective, recent work has identified mecha-
nisms for selective uptake of cytoplasmic proteins into nascent
autophagic vesicles. Selectivity in autophagy is achieved
through cargo recognition by a family of autophagy receptors,
the common feature of which is a functionally conserved LC3-
interacting region (LIR) domain (Hurley and Schulman, 2014;elective autophagy, but how autophagy receptors are orga-
or-suppressor E3 Ub ligase HACE1 ubiquitylates autophagy
of autophagy receptor complex involving OPTN and p62/
reciated mode of regulation for autophagy by Ub signaling.
an tumors, which would cause deficiency in autophagy that
argeting autophagy in these cases might represent a prom-
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the autophagy receptor to ATG8-family proteins on the surface
of the nascent autophagic vesicle. Currently known autophagy
receptors include p62/Squestosome-1 (p62/SQSTM1, hereafter
referred to as p62), NBR1, NDP52, Nix, Cbl, Stbd1 and OPTN
(Optic neuropathy-inducing protein, Optineurin) (Wild et al.,
2011). Among them, p62 and NBR1 are known to oligomerize
through their N-terminal PB1 (Phox and Bem1p) domains, thus
playing a central role in recruiting and targeting cargoes to auto-
phagosome. So far, multiple autophagy receptors are known to
be involved in selective autophagy in a conceptualized complex
(Johansen and Lamark, 2011; Mijaljica et al., 2012). However, as
yet it remains unclear whether and how multiple autophagy
receptors might actually form complexes and operate concert-
edly to control selective autophagy.
There is also emerging evidence that the functionality of auto-
phagy receptors might be regulated to modulate cellular auto-
phagic activity in response to diverse stimuli. OPTN, a most
recently identified autophagy receptor, has been implicated
genetically in human glaucoma, Paget disease, and amyotrophic
lateral sclerosis (ALS) (Maruyamaet al., 2010;Rezaie et al., 2002).
Recently, TBK1-mediated phosphorylation of OPTN was shown
to promote interaction betweenOPTN and LC3, activating selec-
tive autophagy to clear invading Salmonella (Wild et al., 2011).
OPTN was also found to be ubiquitylated and degraded in
mammalian cells (Shen et al., 2011), but themolecular basis, reg-
ulatory mechanism, and impact of its ubiquitylation on the func-
tion of OPTN as an autophagy receptor remain unclear.
Meanwhile, impaired autophagy has been linked to many
types of malignancies, owing to functional defects in various
pathway components. Allelic loss of the autophagic regulator
Beclin1 leads to increased tumorigenesis in mice, and the
Beclin1 gene was found to be monoallelically deleted in 40%–
75% of sporadic human breast cancers and ovarian cancers
(Liang et al., 1999). Mice lacking Atg5 or Atg7, which are essen-
tial components in autophagy pathway, are defective in auto-
phagy and show elevated rates of spontaneous tumor formation
(Komatsu and Ichimura, 2010). Impaired autophagy was also
widely observed in human lung cancers, with a yet unknown
mechanistic basis (Moscat and Diaz-Meco, 2009). Therefore,
defining the context-specific roles of autophagy in cancer and
the regulatory mechanisms involved will be critical for devel-
oping autophagy-targeted therapeutics against specific types
of cancer (White, 2012).
Here we examined the ubiquitylation status of endogenous
OPTN protein identified and further characterized the E3 Ub
ligase that could mediate the ubiquitylation of OPTN. We also
investigated the impact of such ubiquitylation of OPTN on its
function as an autophagy receptor and a potential tumor
suppressor.
RESULTS
Endogenous OPTN Is Ubiquitylated In Vivo
Previously, OPTN (Figure 1A) was found to be ubiquitylated and
to undergo degradation, but the regulatory mechanisms are
unknown. As shown in Figure 1B, endogenous OPTN in human
HEK293FT cells is heavily modified by ubiquitylation, as as-
sessed by immunoprecipitation (IP) using anti-OPTN antibodies,followed by immunoblotting with antiubiquitin. Of note, the IP
was performed in a modified radioimmunoprecipitation (RIPA)
buffer to remove the ubiquitylated autophagy cargos that might
interact with the ubiquitin binding in ABIN and NEMO (UBAN)
domain of OPTN. Moreover, because the autophagy inhibitor
bafilomycin (Baf) rather than the proteasome inhibitor bortezo-
mib (BTZ) seemed to stabilize endogenous OPTN (Figure S1A
available online), cells were treated with Baf prior to the IP using
anti-OPTN. The high-molecular-weight signal of modified OPTN
was eliminated after incubation with Usp2cc, the catalytic core
of human ubiquitin-specific protease 2 (USP2), confirming that
endogenous OPTN was indeed ubiquitylated in HEK293FT cells
(Figure S1B).
Tumor Suppressor E3 Ub Ligase HACE1 Interacts with
and Ubiquitylates OPTN
We next sought to identify the E3 Ub ligase responsible for the
ubiquitylation of OPTN, using yeast two-hybrid (Y2H) screening
(Fields and Song, 1989). Human OPTN was employed as the
bait to screen potential OPTN-interacting proteins from an Y2H
prey library containing open reading frames (ORFs) from human
cDNAs encoding over 400 putative ubiquitin ligases or their
substrate binding subunits. Positive colonies were selected
and found to harbor the prey vector expressing the HECT
domain and ankyrin repeat containing E3 Ub ligase (HACE1).
HACE1-OPTN interaction was indicated by colony formation
on yeast SD-Leu-Trp-His-Ura (SD-4) selection media as well as
plate assays for b-galactosidase activity (Figure 1C). HACE1, a
member of the HECT family of Ub ligases, consists of an
N-terminal stretch of six ankyrin repeats, the C-terminal HECT
ubiquitin ligase domain, and a connecting linker sequence (Fig-
ure 1A). When using HACE1 as bait, Y2H screening also revealed
that OPTN interacted with wild-type HACE1 as well as
HACE1C876S, the E3 Ub ligase activity dead mutant (Figure 1D),
suggesting that the Ub ligase activity is not required for such
interaction. It was previously reported that genetic ablation of
HACE1 promotes tumorigenesis in multiple tissues of mice and
that downregulation or mutation of HACE1 is associated with
multiple human malignancies, which established HACE1 as
a potent tumor suppressor (Zhang et al., 2007). However, the
mechanism underlying the tumor-suppressive function of
HACE1 remains unknown.
In vivo, both tagged and endogenous HACE1 and OPTN
proteins seemed to indeed form a complex that could survive
themultistep procedure in coimmunoprecipitation (CO-IP) assay
(Figures 1E and 1F). GST pull-down assays showed that OPTN
directly interacted with HACE1 in vitro, probably through the
N-terminal ankyrin repeats of HACE1 (Figures 1G and 1H).
Reciprocal pull-down assay also mapped the 411–456 residues
in OPTN as the major HACE1-interaction region (HIR) (Figures
1A, 1I, and 1J). HACE1 and OPTN, tagged respectively with
green fluorescence protein (GFP) and red fluorescence protein
(RFP), did colocalize mostly in extranuclear region of the cell
(Figure S1C).
To examine whether HACE1 actually catalyzes the ubiquityla-
tion of OPTN, we assembled an in vitro ubiquitylation system that
contained ATP, the E1 Ub-activating enzyme (Uba1), the E2 Ub
conjugating enzyme (UbcH7), the substrate (OPTN), and the E3
ub ligase (HACE1). As shown in Figure 2A, wild-type HACE1Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc. 107
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Figure 1. Human OPTN Interacts with HACE1 In Vitro and In Vivo
(A) Schematic representation of the domain architecture of OPTN. LIR, LC3-interacting region; UBAN, ubiquitin binding in ABIN and NEMO domain; ZnF, zinc
finger; Ank, ankyrin repeats; HECT, homologous to the E6-AP carboxyl terminus; HIR, HACE1-interacting region.
(B) Endogenous OPTN was ubiquitylated in HEK293FTcells. OPTN was immunoprecipitated from HEK293FT cells using anti-OPTN in modified RIPA buffer,
followed by immunoblotting with anti-Ub. (See Figure S1C for information on shRNA targeting OPTN.)
(C andD) HumanOPTN interactedwith the tumor suppressor HACE1 in Y2H system. UsingOPTN (C) or HACE1 (D) as bait, HACE1 interactswithOPTN in yeast. In
(D), HACE1C876S was also used as bait. OPTN and HACE1 or HACE1C876S cotransformed into yeast strain Mav 203-activated expression of b-glycosidase. SD-2,
deficient in Leu and Trp; SD-4, deficient in Leu, Trp, His, and Ura; C876S, the HACE1 active site Cys876-to-Ser mutant.
(E–J) OPTN interacted with HACE1. Coimmunoprecipitation assay shows that tagged (E) or endogenous (F) OPTN and HACE1 formed a complex in HEK293FT
cells. GST pull-down assays indicates that recombinant GST-tagged HACE1, but not GST, interacts only with HA-tagged OPTN (G). The N-terminal ankyrin
repeats of HACE1 (H) and the fragment-spanning residues 411–456 of OPTN are implicated in such interaction (I and J).
See also Figure S1.
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UBAN domain of OPTN. HACE1-conjugated ubiquitin chains
on OPTN were primarily in Lys27 and Lys48 Ub linkages in vivo
because Ub containing Lys27 or Lys48 as the only Lys residue
was conjugated efficiently but Ub with Lys27-to-Arg (K27R) or
Lys48-to-Arg (K48R) mutation was not (Figures 2B and 2C).
Furthermore, knocking down endogenous HACE1 in HEK293
cells with short-hairpin RNA efficiently blocked the formation of
polyubiquitin (poly-Ub) chains on OPTN (Figures S1E, S2A, and
S2B), suggesting that endogenous HACE1 might be the major
E3 Ub ligase ubiquitylating OPTN in HEK293 cells.108 Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc.HACE1-Mediated Lys48-Linked Poly-Ub Chains Target
OPTN for Autophagic Degradation
Knowing that endogenous OPTN was stabilized by autophagy
inhibitor Baf but not as much by proteasome inhibitor BTZ (Fig-
ure S1A), we are particularly interested in which Lys48-linked
poly-Ub chain would target OPTN for. As shown in Figure 2D,
interestingly, Lys48-linked polyubiquitylation of OPTN turned
out to be slightly stabilized in cells treated with BTZ but accumu-
lated significantly when autophagy was inhibited upon Baf
treatment. The Lys48-linked polyubiquitylation of OPTN also
accumulated in autophagy-deficient ATG7 / cells, suggesting
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Figure 2. Tumor Suppressor HACE1 Ubiquitylates OPTN with Lys27 and Lys48 Ubiquitin Linkages and on Multiple Lys Residues of OPTN,
Including Lys193
(A) Human HACE1 ubiquitylated OPTN in vitro. An in vitro ubiquitylation assay was carried out using the recombinant proteins OPTN-HA, E1, UbcH7 as E2, and
HACE1, together with the indicated components.
(B and C) HACE1-ubiquitylated OPTN with Lys27 and Lys48 ubiquitin linkages. HEK293FT cells expressed HACE1-Myc, and HA-Ub (Lys6, Lys11, Lys27, Lys29,
Lys33, Lys48, or Lys63 only) as indicated (B); HEK293FTcells stably overexpressing HACE1-Myc were transfected with HA-Ub (wild-type, WT; knockout, KO;
Lys27; K27R; Lys48; or K48R) as indicated (C).
(D) OPTN with Lys48-linked poly-Ub chains is stabilized on autophagy inhibition. ATG7+/+ or ATG7/ MEF cells were cotransfected with HA-Ub (Lys48) and
Flag-OPTN as indicated, and OPTN was immunoprecipitated with anti-FlagM2 beads and immunoblotted with anti-HA antibodies to detect ubiquitylated OPTN.
Baf is an autophagy inhibitor.
(E) Schematic distribution of the 13 Lys residues in OPTN ubiquitylated by HACE1 in vitro. Mass spectra analyses were performed on OPTN recovered from an
in vitro ubiquitylation assay. Lys501 ubiquitylation was reported elsewhere (Kim et al., 2011).
(F) Lys-to-Arg substitution at all 13 ubiquitylation sites in OPTN almost abolished HACE1-mediated ubiquitylation of OPTN. HEK293FTcells were transfected with
Flag-tagged wild-type OPTN or its poly-Lys-to-Arg mutants. Note that the conjugated ubiquitin in this experiment was endogenous.
(G) Lys193 is one of themajor sites for HACE1-mediated ubiquitylation onOPTN. HEK293FT cells were transfected with HA-taggedwild-typeOPTN or itsmutants
bearing single Lys-to-Arg substitutions at all potential ubiquitylation sites (also see Figures S2E and S2F).
See also Figure S2.
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Figure 3. HACE1 and OPTN Activate Autophagy
(A and B) Endogenous OPTN is an autophagy substrate. Compared with wild-type MEF cells, OPTN was accumulated in autophagy-deficient ATG7 /mouse
MEF cells (A). Treatment with rapamycin (Rapa, 10 mg/ml) induced the degradation of endogenous OPTN, whereas the Baf (20 nM) or 3-MA (10 mM) blocked the
degradation of endogenous OPTN in HEK293FT cells (B).
(C–E) HACE1-mediated ubiquitylation activated autophagy in human lung cancer cells. Overexpression of Flag-tagged HACE1, but not its catalytically inactive
mutant HACE1C876S, increased the ratio of [LC3 II]/[LC3 I] (C). Fluorescence microscopy shows the formation of GFP-LC3 puncta in CRL-5872 cells transfected
(legend continued on next page)
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HACE1-OPTN Activates Autophagy to Suppress Tumorthat OPTN with Lys48-linked poly-Ub chains might be pre-
dominantly targeted for autophagy-dependent degradation.
Autophagy activator rapamycin destabilized endogenous
OPTN protein, whereas genetic ablation of the ATG7 gene or
treatment with the autophagy inhibitor 3-methyladenine (3-MA)
had the opposite effect, suggesting that endogenous OPTN
indeed undergoes autophagic degradation (Figures 3A and
3B). These observations depart from the generally accepted
notion that proteins with Lys48-linked poly-Ub chains are
exclusively targeted to proteasome-dependent degradation
(Chau et al., 1989; Deshaies and Joazeiro, 2009; Finley, 2009;
Finley et al., 2004; Komander and Rape, 2012; Weissman
et al., 2011). Notably, it has been reported that Lys48-linked
ubiquitin conjugates accumulate when autophagy is impaired
(Riley et al., 2010).
Lys193 in OPTN Is One of the Major Sites for HACE1-
Mediated Ubiquitylation
After an in vitro ubiquitylation reaction, ubiquitylated OPTN was
recovered (Figure S2C) and subjected to tryptic digestion, fol-
lowed by mass spectra (MS) analysis. The attachment of ubiq-
uitin to the side chain of a Lys residue renders it resistant to
trypsin cleavage, and tryptic digestion of ubiquitin (chains)
attached to the site leaves a -Gly-Gly- group, originating from
the C terminus of ubiquitin, on the side chain of the modified
Lys (Kim et al., 2011). Based on these signature features, ubiq-
uitylation sites in OPTN were identified from tandem mass
spectrometry (MS/MS) spectra. Altogether, a total of 12 Lys
residues were found to be ubiquitylated by HACE1 in vitro
(Figure 2E; Figure S2D).
We then asked which Lys residues in OPTN might be the
major ubiquitylation sites in vivo. We generated OPTN mutants
bearing single or multiple Lys-to-Arg substitutions in every po-
tential ubiquitylation site. As shown in Figure 2F, Lys-to-Arg
substitutions on all the potential ubiquitylation sites indeed
almost completely abolished the HACE1-catalyzed ubiquityla-
tion on OPTN in vivo. Remarkably, Ub conjugation to OPTN
mutant with Lys193-to-Arg (K193R) substitution (OPTNK193R)
was substantially reduced compared with that of either wild-
type OPTN or any mutant bearing single Lys-to-Arg subs-
titutions on each of the other ubiquitylation sites (Figure 2G;
Figures S2E and S2F). This result suggested that ubiquitylation
on Lys193, which reside close to the LIR motif in OPTN
(Figure 1A), might be functionally important. Therefore we pro-
ceeded to investigate the biological consequences of HACE1-
mediated ubiquitylation on OPTN, particularly that taking place
on Lys193.with indicated plasmids. The autophagy inducer rapamycin (Rapa, 10 mg/ml) wa
inhibitor. Statistics of the puncta formation by GFP-LC3 in the indicated samples
images with the cell nuclei stained using DAPI (E).
(F) Co-expression of HACE1- and OPTN-activated autophagy removes carbony
20 nM) is an autophagy inhibitor.
(G and H) HACE1-mediated ubiquitylation promoted the removal of carbonylate
activity of HACE1 (G) and the ubiquitylation of Lys193 in OPTN (H). Pyocyanin (PC
negative control. The expression of the genes of interest was probed with the in
proteins were visualized through derivatization with DNPH, followed by immunob
proteins (CRCPs; in nanomoles per milligram total proteins) were determined u
details).
See also Figure S3.Lys193 in OPTN Is Not Involved in the Interaction
between OPTN and LC3 II
Since Lys193, a major site for HACE1-conjugated ubiquitylation
on OPTN, resides close to the LIR (Phe178 Val-Glu-Ile181) of
human OPTN, it was natural to ask whether above K193R muta-
tion in OPTN would have any effect on the interaction between
LC3 and OPTN. A glutathione S-transferase (GST) pull-down
assay was thus performed between bacterially expressed LC3
and wild-type OPTN or the OPTNK193R mutant. As shown in
Figure S2H, compared to that of wild-type OPTN, the K193R
mutation in OPTN seemed to have no appreciable effect on the
interaction between GST-tagged LC3 and OPTN, suggesting
that OPTNK193R might be structurally intact, at least in terms of
its affinity to LC3.
OPTN and HACE1 Are Downregulated inMultiple Human
Lung Cancer Cells
The HECT family of ubiquitin ligases has been known to play
multiple roles in cancer development (Bernassola et al., 2008;
Rotin and Kumar, 2009). Specifically, HACE1 has been recog-
nized as a potent tumor suppressor because previous work
has shown that HACE1 is inactivated or downregulated in multi-
ple types of human malignancies, such as Wilms tumor (Diskin
et al., 2012; Zhang et al., 2007). In addition, sporadic tumors
occurred frequently in various tissues of HACE1-knockout
mice (Zhang et al., 2007). Impaired autophagy was also widely
observed in human malignancies, including lung cancers, with
the mechanism yet unknown (Moscat and Diaz-Meco, 2009).
Interestingly, an analysis of a recently published data set
revealed a strong correlation between the higher expression of
OPTN and better relapse-free survival in 1,715 lung cancer
patients (Gyo¨rffy et al., 2010) (Figure S3F). Meanwhile, highly
frequent mutations in the OPTN or HACE1 gene were uncovered
in 13 different human cancer types, according to data extracted
from The Cancer Genome Atlas (TCGA) data sets (Cerami et al.,
2012; Gao et al., 2013) (Figures S3D and S3E). Taken together,
these results strongly underscored the potential tumor-
suppressing roles of OPTN and HACE1 in human malignancies,
including lung cancer.
Therefore, we used lung cancer cells as a model to directly
assess the potential association between lung cancer and the
downregulation of OPTN and/or HACE1. We first surveyed the
expression of OPTN and HACE1 in multiple lung cancer cell lines
from the American Type Culture Collection (ATCC). In these
cells, the levels of OPTN protein appeared to be low in three
lines. CRL-5872 cells were then selected for subsequent studies
because they expressed endogenous HACE1 and OPTN at fairlys used as a positive control; 3-methyladenine (3-MA, 10 mM) is an autophagy
; data are presented in mean ± SEM. ***n = 10, p < 0.001 (D). Representative
lated proteins in the human lung cancer cells (CRL-5872). Baflinomycin (Baf,
d proteins in human lung cancer cells (CRL-5872) dependent on E3 Ub ligase
N) was used as a positive control, and N-acetyl-L-cysteine (NAC) was used as a
dicated antibodies. Actin was also probed for loading control. Carbonylated
lotting with anti-2,4-dinitrophenol (DNP). The contents of residual carbonylated
sing absorbance at 370 nm for each group (see Experimental Procedures for
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of the exogenous wild-type HACE1, OPTN, or their indicated
mutants free of potential interference from the endogenous
counterparts.
HACE1-OPTN Promotes the Formation of LC3 Puncta
and Lipidation of LC3 II in Human Lung Cancer Cells
Previous studies established OPTN as an autophagy receptor,
and phosphorylation of OPTN by TBK1 on Ser177 was shown
to promote autophagic clearance of Salmonella (Wild et al.,
2011). Accordingly, we asked whether HACE1-mediated ubiqui-
tylation of OPTN might impact cellular autophagic activity
through monitoring and assessing LC3-containing puncta, the
lipidation of LC3 (the ratio of [LC3 II] to [LC3 I]) and cellular
autophagic flux (Klionsky et al., 2012).
Consistently, only the expression of wild-type HACE1, but not
HACE1C876S, resulted in increased levels of phosphatidyl-
ethanolamine (PE)-modified LC3 (LC3-II-PE), with concomitant
increase in OPTN ubiquitylation (see the ratio of [LC3 II] to
[LC3 I], Figure 3C). As shown in Figures 3D and 3E, fluorescence
microscopic analysis with the reporter cell line CRL-5872 stably
expressing GFP-LC3 and subsequent quantitation revealed that
overexpression of human HACE1 or OPTN alone induced the
formation of the GFP-LC3 puncta, similar to, but to a lesser
extent than, that observed in cells treated with rapamycin, a
known autophagy inducer. Coexpression of exogenous OPTN
and HACE1 further enhanced the formation of GFP-LC3 puncta,
whereas the enzymatically inactive HACE1mutant, HACE1C876S,
did not, suggesting the E3 Ub ligase activity of HACE1 was
important for the induction of puncta formation. Remarkably,
this effect was almost abolished when OPTNK193R was coex-
pressed with HACE1, suggesting that HACE1-mediated ubiqui-
tylation on Lys193 was critical for the induction of LC3 puncta
formation (Figure 3E). Consistent data were also obtained using
endogenous LC3, as indicated by immunomicroscopy analysis
using anti-LC3 antibodies (Figure S3J). Moreover, significantly
fewer LC3 puncta were formed in the cells that overexpressed
HACE1 but had endogenous OPTN knocked down with RNA
interference (Figure S3J), suggesting that HACE1-induced auto-
phagy might be OPTN dependent.
Therefore, HACE1-mediated ubiquitylation of OPTN appeared
to activate autophagy.
HACE1-OPTN Promotes Autophagic Removal of p62/
SQSTM1 and Oxidatively Damaged Proteins in Human
Lung Cancer Cells
The accumulation of protein carbonyl groups is a biomarker of
cellular oxidative stress and compromise in cellular proteolytic
capacity (Dalle-Donne et al., 2003). Cellular levels of oxidatively
damaged proteins can be efficiently assessed by derivatizing
the carbonyl groups with hydrazines such as 2,4-dinitrophenyl-
hydrazine (DNPH), followed by immunoblotting with anti-DNP
antibodies to visualize the carbonylated proteins. Meanwhile,
the DNP group also has a characteristic absorbance at
370 nm, making possible a facile quantitative assay of the con-
tent of carbonyl groups on a pool of proteins. Normally, oxida-
tively damaged proteins are removed in timely manner, largely
through autophagy because their degradation could be pro-
moted by rapamycin, but this process could be blocked by the112 Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc.autophagy inhibitor 3-MA or Baf stabilizing them (see also Fig-
ure S3G). N-acetyl-cysteine (NAC) effectively scavenges cellular
oxidants, whereas pyocyanin (PCN) is a secondary metabolite
from Pseudomonas aeruginosa that can drastically increase
the oxidative flux of cellular proteins. Therefore, cellular protein
oxidation can be reliably gauged through anti-DNP blotting using
cells treated with NAC or PCN as negative or positive controls,
respectively.
As shown in Figure 3F, the overexpression of wild-type OPTN
alone slightly decreased the total level of oxidized proteins in the
lung cancer cells. Strikingly, coexpression of wild-type HACE1
and OPTN reduced the cellular level of oxidized proteins so
much that signal became barely detectable in anti-DNP blotting,
which could be reversed by addition of Baf or by knocking down
HACE1. Further experimentation with the ligase-activity-dead
HACE1C876S or OPTNK193R, the OPTN mutant that harbored
Lys-to-Arg substitution on Lys193, indicated that HACE1-medi-
ated ubiquitylation on Lys193 of OPTN is critical for the removal
of the carbonylated proteins during autophagy activated by
HACE1-OPTN (Figures 3G and 3H). p62 and oxidized proteins
were accumulated in human lung cancer cells (CRL-5872) (Fig-
ure S3H). Similarly, when endogenous OPTN was knocked
down with shRNA, the overexpression of wild-type HACE1 alone
did not increase removal of p62 or cellular oxidized proteins (Fig-
ure S3H). Interestingly, p62 and oxidized proteins remained high
in cells overexpressing both wild-type HACE1 and OPTNK193R
(Figure 5A; Figure S6C). Taken together, these results suggested
that HACE1-mediated ubiquitylation of OPTN, particularly that
taking place on Lys193, might be essential for activating auto-
phagy, as determined by the removal of oxidatively damaged
proteins, the conversion of LC3 I into lipidated LC3 II, and the
degradation of p62 (Figures 3C–3H; Figure S3H).
HACE1 and OPTN Form a Functional Axis to Promote
p62-Dependent Autophagy
We next used macrophages derived from either OPTN wild-type
(OPTN +/+) or knockout (OPTN /) mice (Skarnes et al., 2011) to
further investigate the role of OPTN during HACE1-activated
autophagy. As shown in Figure 4A, in OPTN +/+ macrophages
the overexpression of HACE1, but not the catalytically inactive
HACE1C876S, induced significantly more conversion of LC3 I
into LC3 II in lipidated form, the removal of p62 or oxidized pro-
teins. However, in OPTN / macrophages, neither p62 nor the
cellular oxidized proteins were eliminated to a greater extent
than in control cells regardless of the expression of HACE1 or
HACE1C876S. This strongly suggested that the existence of
endogenous OPTN is required for HACE1-activated autophagy
(Figure 4A).
Interestingly, in p62 / mouse embryonic fibroblast (MEF)
cells the HACE1-OPTN axis did not promote the autophagic
removal of oxidatively damaged proteins either. However, this
could be reversed when wild-type human p62 was reintroduced
into the cells (Figure 4B), suggesting that the HACE1-OPTN axis
might accelerate p62-dependent cellular autophagic flux.
Interestingly, even in the presence of p62, K193R mutation in
OPTNmarkedly compromised the autophagy-promoting activity
of the HACE1-OPTN axis, suggesting that HACE1-mediated
ubiquitylation on Lys193 of OPTN might functionally interact
with p62. It is intriguing to ask whether the HACE1-conjugate
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Figure 4. HACE1 and OPTN Form a Func-
tional Axis to Activate p62/SQSTM-Depen-
dent Autophagy
(A) HACE1-mediated ubiquitylation accelerated
the removal of carbonylated proteins in an OPTN-
dependent manner. Macrophage cells were iso-
lated from OPTN +/+ and OPTN –/– mice, cultured,
and transfected with plasmids encoding HACE1 or
HACE1C876S.
(B) HACE1-mediated ubiquitylation of Lys193 in
OPTN promoted the degradation of oxidized
proteins in p62/SQSTM1 / MEF cells over-
expressing p62-Flag.
(C) Endogenous OPTN, HACE1, and p62 form a
complex in OPTN +/+ cells.
(D) Endogenous HACE1 ubiquitylates OPTN in
HEK293FT cells and promotes its interaction with
p62. OPTN was immunoprecipitated from extracts
of OPTN +/+or HEK293FT cells using anti-OPTN,
followed by immunoblotting with anti-OPTN, anti-
HACE1, or anti-p62 antibodies. IgG served as a
negative control.
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HACE1-OPTN Activates Autophagy to Suppress Tumorpoly-Ub chain on Lys193 of OPTN would directly interact with
p62, whose ubiquitin-associated (UBA) domain was known to
bind to Lys48 or Lys63-linked poly-Ub chains (Ciani et al., 2003).
HACE1-Mediated Ubiquitylation of Lys193 in OPTN
Promotes the Formation of p62/SQSTM1-OPTN
Complex
As shown in Figure 4C, in OPTN +/+ MEF cells, endogenous
HACE1, OPTN, and p62 did physically interact to form a com-
plex. However, knocking down HACE1 or OPTN with RNA
interference abolished the interaction. Furthermore, removing
poly-Ub chains on immunoprecipitated OPTN with deubiquiti-
nating enzyme Usp2cc also disrupted OPTN-p62 interaction
but not HACE1-OPTN interaction, suggesting that HACE1-medi-
ated ubiquitylation of OPTN might be critically involved into
OPTN-p62 interaction (Figure 4D).
As shown in Figure 5A, in lung cancer cells that overexpress
wild-type HACE1 and OPTN, OPTN was ubiquitylated and inter-
acted with endogenous p62. However, in cells overexpressing
OPTNK193R andwild-typeHACE1,muchweaker or no interaction
between OPTNK193R and p62 was detected, despite the fact that
they had higher levels of endogenous p62 protein. Meanwhile, in
mouse p62-knockout embryonic cells (p62 / MEF) (Komatsu
et al., 2007) expressing humanHACE1, full-length p62 interactedCancer Cell 26, 106–with HACE1-ubiquitylated OPTN, which
could be abolished by the deletion of
the UBA domain in p62. Similarly,
much weaker interaction was observed
between OPTNK193R and the overex-
pressed p62 (Figure 5B). These data
suggested that the UBA domain of p62
and HACE1-conjugated Ub chains on
Lys193 of OPTN were critically involved
into OPTN and p62 interaction in vivo.
As shown in Figure 5C, OPTN ubiquity-
lated by HACE1 in vitro interacted with
UBA domain of p62, but the unmodifiedOPTN did not (Figure 5C). Meanwhile, there was little or no inter-
action observed between p62 and OPTNK193R, when the latter
was marginally ubiquitylated by HACE1 in vitro (Figure 5D). As
shown in Figures 5E and 5F, only the Lys48-linked poly-Ub chain
that HACE1-conjugated onto OPTN interacted with the p62
in vitro, whereas the Lys27-linked one did not. This suggested
that p62 preferential bound to ubiquitylated OPTN in Lys48 Ub
linkage.
The HACE1-OPTN Axis Accelerates Degradation of p62,
Suppresses ROS Production, and Mitigates Oxidative
DNA Damage in Human Lung Cancer Cells
Autophagy receptor p62 is also a known substrate for selective
autophagy (Komatsu and Ichimura, 2010). Specifically, levels
of endogenous p62 in mouse OPTN/ macrophage cells were
significantly higher than those in the wild-type cells, which could
be reversed by the reintroduction of wild-type OPTN (Figure 4A).
A similar effect was also observed in CRL-5872 cells that
express endogenous OPTN at a low level, where level of endog-
enous p62 went down on coexpression of wild-type HACE1 and
OPTN (Figure 5A). However, the coexpression of wild-type
HACE1 and OPTNK193R did not reduce the level of endogenous
p62, which strongly suggested that accelerated degradation of
p62 was mainly dependent on HACE1-mediated ubiquitylation120, July 14, 2014 ª2014 Elsevier Inc. 113
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Figure 5. HACE1-Mediated Ubiquitylation of Lys193 in OPTN Promotes the Interaction between OPTN and p62/SQSTM1 to Activate
Autophagy
(A) HACE1-mediated ubiquitylation of Lys193 in OPTN promoted the interaction between OPTN and endogenous p62/SQSTM1 in CRL-5872 cells.
(B and C) The UBA domain in p62 interacted with HACE1-ubiquitylated OPTN. The p62 /MEF cells were infected with lentivirus for the expression of HACE1,
HA-tagged wild-type OPTN or OPTNK193R, the full-length p62, or its UBA domain deletion mutant, p62DUBA in the indicated combinations; OPTN or OPTNK193R
was immunoprecipitated using anti-HA (B). Bacterially expressed OPTN was ubiquitylated using HACE1 in vitro and interacted with p62 but not p62DUBA (C).
(D) Bacterially expressed p62/SQSTM1 interacted with OPTN through poly-Ub chains that HACE1 conjugated onto Lys193 in OPTN in vitro.
(E and F) Bacterially expressed p62 interacted Lys48-linked poly-Ub chains (E) but not Lys27-linked poly-Ub chains (F) that HACE1-conjugated onto OPTN.
(G) Bacterially expressed NBR1 did not interact with HACE1-ubiquitylated OPTN. The presence of the indicated proteins was confirmed using immunoblotting
with the respective antibodies.
See also Figure S4.
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HACE1-OPTN Activates Autophagy to Suppress Tumorof Lys193 inOPTN. In HEK293FT cells, knocking downHACE1 or
OPTN also led to an appreciable increase in the static level of
endogenous p62 protein (Figure 4D). Therefore, the coexpres-
sion of HACE1 and OPTN appeared to promote the interaction
between autophagy receptors OPTN and p62 and to accelerate
the autophagic degradation of p62.
Taking samples from those for Figure S3H, through IP with
anti-DNP followed by quantitative MS analysis, our data clearly
indicated that coexpression of HACE1 and OPTN could signifi-
cantly reduce the carbonylation of more than 60 cellular proteins
in CRL-5872, including heat shock protein 70 KDa protein 8 (data
not shown).
Previous work demonstrated that p62 is also a positive regu-
lator of cellular reactive oxygen species (ROS) production and
that ROS at an elevated level triggers the translocation of nuclear
factor (erythroid-derived 2)-like 2 (Nrf2) into the nucleus, thus
activating Nrf2-mediated p62 transcription (Komatsu et al.,
2010). These findings suggest a feedback mechanism between
p62 and intracellular ROS production. During the autophagy
activated by the HACE-OPTN axis, the accelerated removal of
p62 and the oxidatively damaged proteins would significantly
suppress ROS production. Indeed, the production of ROS in
cells expressing both wild-type HACE1 and OPTN was less
than 10% of that in control cells (Figures S4A–S4F). Similar
results were observed in DNA damage assays, with cells
expressing both HACE1 and OPTN (see Figure S4G).
An excess of p62 is known to be associated with multiple type
of human cancer, and the elimination of p62 has been well
accepted as one of the major mechanisms through which auto-
phagy suppresses tumorigenesis (Komatsu et al., 2010; Mathew
et al., 2009). The HACE1-OPTN axis might suppress ROS pro-
duction and mitigate oxidative DNA damage, most likely through
promoting autophagic removal of p62 and the other oxidatively
damaged proteins (Figure S3H).
The HACE1-OPTN Axis Suppresses Anchorage-
Independent Growth of Human Lung Cancer Cells
We proceeded to investigate the potential tumor-suppressive
effect of the HACE1-OPTN axis. A tumor-colony-formation
assay was performed using lung cancer cells (CRL-5872)
expressing wild-type HACE1, OPTN, both, or their indicated
mutants (Figures 6A–6B; Figure S5A). Cancer cells expressing
wild-type HACE1 formed approximately 58% fewer colonies in
soft agar than did control cells transfected with empty vectors.
Cells expressing the catalytically inactive HACE1C876S formed
almost as efficiently as the controls did. This result is consistent
with the previous observation that the ubiquitin ligase activity of
HACE1 is critical for its potent suppressive effect on the
anchorage-independent growth of the cancer cells (Zhang
et al., 2007). The overexpression of OPTN alone inhibited tumor
proliferation by approximately 63%. This strongly suggested that
OPTN might also function as a tumor suppressor in lung cancer
cells, which was reminiscent of the previous finding that higher
OPTN expression strongly correlated with better relapse-free
survival in human lung cancer patients (Figure S3F).
Strikingly, cancer cells expressing both wild-type HACE1 and
OPTN formed colonies at a frequency less than 10% of the
control cells’ frequency, suggesting that HACE1 and OPTN
could synergistically suppress tumor growth. In contrast, cancercells that coexpressed wild-type OPTN and the enzymatically
inactive HACE1C876S formed 63% more colonies than the con-
trols. Similar results were observed with cancer cells that
expressed wild-type HACE1 but had endogenous OPTN or
p62 knocked down through RNA interference (Figures 6A and
6B; Figures S5A, S5E, and S5F), suggesting that the tumor-
suppressive function of HACE1 is dependent on the presence
of endogenous OPTN, p62, and the Ub ligase activity of
HACE1 (Figures S5C and S5G).
Interestingly, in the cancer cells that overexpressed wild-type
HACE1 and OPTNK193R, the inhibitory effect of HACE1 on tumor
colony formation was partially abrogated (Figures 6A and 6B). In
contrast, Lys-to-Arg substitution on every ubiquitylation site
other than Lys193 of OPTN still synergistically suppressed
tumors with HACE1. Therefore, the ubiquitylation on Lys193
of OPTN, which was demonstrated to be critical for
HACE1-activated autophagy, also significantly contributed to
the HACE1-mediated suppression of tumor colony formation.
The HACE1-OPTN Axis Suppresses Tumorigenicity
of Human Lung Cancer Cells in Nude Mice
Subsequently, a tumorigenicity model of cancer cells in nude
mice was employed to further probe the tumor-suppressive
effect of HACE1-mediated ubiquitylation on OPTN in vivo. As
shown in Figure S5C, the lung cancer cells (CRL-5872) stably
expressing wild-type HACE1, OPTN, or mutant forms of these
proteins were injected into nude mice. The efficiency of tumori-
genicity of the cancer cells in each group was assessed
21 days after the injection (Figures 6C and 6D). CRL-5872 cells
expressing either exogenous HACE1 or OPTN alone formed
tumors of sizes significantly smaller (38% or 25%, respectively)
than those in the control group. Cancer cells with endogenous
OPTN knocked down formed tumors approximately 87% larger
than the controls, which again suggested a tumor-suppressing
function for OPTN. In cancer cells stably expressing both
HACE1 and OPTN, the size of tumor formation was only one-fifth
of that of the control, indicating a synergistic tumor-suppressing
effect of the HACE1-OPTN axis. Interestingly, cancer cells that
expressed HACE1 but had endogenous OPTN knocked down
formed tumors in nudemice67% larger than that of the control.
Remarkably, cancer cells expressing HACE1 with OPTNK193R
formed tumors129% larger than that in the control. In contrast,
cancer cells expressing HACE1 and OPTN that harbored Lys-
to-Arg substitutions on all potential ubiquitylation sites except
Lys193 in OPTN (OPTNK193only) formed tumors of 51 percent
smaller size than those of the control. This result highlighted
the possibility that tumor suppression by the HACE1-OPTN
functional pair might be largely mediated by the HACE1-
conjugated poly-Ub chain on Lys193 residue of OPTN.
The HACE1-OPTN axis also critically modulates cellular auto-
phagy in the actual tumors depending on the ubiquitylation of
Lys193 OPTN, as assessed by assaying the increased formation
of lipidated LC3 II and the removal of carbonylated proteins
(Figure 6E). Altogether, these data indicated that HACE1-
mediated ubiquitylation of OPTN, particularly that taking place
on Lys193 of OPTN, plays critical role in activating autophagy
to suppress tumorigenicity of the cancer cells in vivo.
Through immunohistochemistry microscopy analyses, we
also examined the levels of endogenous HACE1 and OPTNCancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc. 115
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Figure 6. HACE1-Mediated Ubiquitylation of OPTN Induces Autophagy, Suppressing Anchorage-Independent Growth and Tumorigenicity of
Human Lung Cancer Cells in Nude Mice
(A and B) HACE1-mediated ubiquitylation of OPTN inhibits anchorage-independent proliferation of human lung cancer cells, CRL-5872. The representative
images show typical colony formation by cells expressing the indicated genes 14 days after cell plating (A). The colony-formation efficiency of each group was
assessed in percentages of that for the control (B). Data are presented in mean ± SEM. ***n = 3, p < 0.001.
(C–E) HACE1-mediated ubiquitylation of OPTN, particularly on Lys193 of OPTN, activates autophagy and suppresses tumorigenicity of the lung cancer cells in
nude mice. Images show tumor formation in nude mice (C) and the dissected tumors 21 days after injection (D). Tumor masses for each group are shown in
mean ± SEM. ***n = 6, p = 0.001; *n = 6, p = 0.0177. Expression of the genes of interest in the xenografts were examined using immunoblotting (E). The ratios of the
static level of lipidated LC3 II to that of LC3 I, [LC3 II]/[LC3 I], were assayed for autophagic activities in the tumors. The contents of the residual carbonylated
proteins (CRCPs, in nanomoles per milligram total proteins) were assessed for each group of the tumor masses. Data are shown in mean ± SEM (n = 3).
***p < 0.001.
See also Figure S5.
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normal tissues as controls. Indeed, HACE1 and OPTN appeared
to be downregulated in multiple cancers, such as liver cancer
(Figures 7A–7D) and stomach or lung cancer (Figure S6). The
results further underscored the existence of a strong association
between human malignancies and the deficiency of the HACE1-
OPTN axis.
DISCUSSION
Through recruiting and delivering cargo to autophagosome,
receptors are known to play pivotal roles in selective autophagy.116 Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc.However, the distinct domain structures of the different auto-
phagy receptors actually distinguish one receptor from another.
For example, p62 and NBR1 are known to self-oligomerize
through their N-terminal PB1 domains, whereas the other recep-
tors may not (Itakura and Mizushima, 2011; Kirkin et al., 2009b).
p62 and NBR1 are thus critical in organizing the autophagy
receptor complex and targeting autophagy cargos to autopha-
gosome, followed by autophagic degradation. We report here
that HACE1-mediated ubiquitylation of OPTN, particularly that
taking place on Lys193, might activate autophagy through pro-
moting the physical interaction between the autophagy recep-
tors OPTN and p62. Therefore, in addition to the previously
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Figure 7. The HACE1-OPTN Axis Suppresses Tumor through Promoting Formation of the Complex of Autophagy Receptors
(A–D) HACE1 and OPTN are downregulated in human liver cancer. Representative immunohistochemical staining images of HACE1 (A) and OPTN (B) in human
liver cancer and adjacent tissues. Statistics scores of the staining of HACE1 (C) and OPTN (D) in human liver cancer and adjacent tissues. Data are presented in
mean ± SEM. ***n = 30. For HACE1, p < 0.001; for OPTN, p = 0.0027. (See Supplemental Experimental Procedures for more details).
(E) A model depicting how the HACE1-OPTN axis might suppress tumor through promoting autophagy in vivo.
See also Figure S6.
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ceptors, selective autophagy also seemed to be controlled by
delicately regulated interactions between autophagy receptors.
Our data not only underscore the critical role of p62 in autophagy
but also providemechanistic insight into the functional dynamics
of autophagy receptors during selective autophagy. Particularly,
our findings have strongly suggested the actual existence of a
large complex of multiple autophagy receptors (encompassing
p62 and OPTN), in which the autophagy receptors work in con-
cert to recruit more cargoes and target them for efficient auto-phagic degradation. This model was strongly supported by the
observations that endogenous OPTN, p62, and HACE1 indeed
form a complex and that the formation of such complexes is
dependent on HACE1-mediated ubiquitylation on OPTN, mainly
on its Lys193. In light of the central role of p62 in forming auto-
phagic complex, it is conceivable that such interaction in vivo
could significantly augment the recruitment of the autophagic
cargos to the autophagy receptor complex, including both p62
and OPTN, before targeting to autophagosome. This might
mechanistically account for how the overall cellular autophagicCancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc. 117
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roles of Ub signaling in regulating autophagy (Kuang et al., 2013;
Tasaki et al., 2013), our work has revealed a mechanism through
which the Ub system delicately regulates selective autophagy
through controlling the formation of the autophagy receptor
complex.
In this study, we report that the HACE1-OPTN axis accelerates
the removal of p62, carbonylated proteins, and the total cellular
autophagic flux regardless of cell type. Given the wide range of
cellular functions that these proteins are involved in and the
critical importance of oxidative stress in tumors (Xu et al.,
2011), the removal of these oxidatively damaged proteins along
with p62 and the reduced production of ROS might thus
mechanistically underlie the tumor suppression mediated by
the HACE1-OPTN axis (Figure 7E).
Of note, consistent with previous observations (Komatsu and
Ichimura, 2010; Mathew et al., 2009), our study again shows
that autophagy receptors such as p62 and OPTN are required
for autophagy but also themselves undergo autophagic
degradation. These seemingly paradoxical phenomena exactly
highlight the multiple roles of autophagy receptors in autophagy:
as autophagy cargo carriers, as regulators, and as substrates of
autophagy.
Given the fact that OPTN is critically implicated in neurological
functions and host-microbe interactions (Mankouri et al., 2010;
Maruyama et al., 2010; Wild et al., 2011; Ying and Yue, 2012)
and that the HACE1-OPTN axis activates autophagy regardless
of cell types, our findings may thus be of broad significance.
Particularly, because of the strong association between human
malignancies and the deficiency of HACE1 or OPTN (Diskin
et al., 2012; Zhang et al., 2007), targeting the HACE1-OPTN
axis may thus open an avenue for therapeutic intervention in
cancers.
EXPERIMENTAL PROCEDURES
Reagents and Plasmid Construction
See Supplemental Information for details.
Yeast Two-Hybrid Screen
The Y2H screening was carried out to screen for E3 Ub ligases that may
ubiquitylate OPTN. Using OPTN or HACE1 as bait, HACE1 interacts with
OPTN in yeast. OPTN and HACE1 or HACE1C876S cotransformed into yeast
strain Mav203 can activate the expression of b-glycosidase.
In Vitro and In Vivo Ubiquitylation Assays
In vitro ubiquitylation assays were performed as described in earlier studies
(Kim et al., 2014; Li et al., 2009). Immunoprecipitation with anti-OPTN, followed
by anti-ubiquitin immunoblotting, was performed in a RIPA buffer to check the
ubiquitylation status of endogenous OPTN. See Supplemental Experimental
Procedures for details.
Mass Spectra and Mutagenesis Analyses
MS and mutagenesis analyses were performed to determine the sites of the
poly-Ub chains that HACE1 conjugates to OPTN.
Growth-Independent Colony Formation and Tumorigenicity Assays
Human lungcancer cells (CRL-5872), cotransfectedwithHACE1,OPTN,or their
mutants, were subjected to a colony-formation assay on soft agar or to tumor-
igenicity experiments in nude mice. Soft agar colony-formation assays were
carried out as described in an earlier study (Li et al., 2010). The tumorigenicity
assay of the lung cancer cells in nude mice was performed in CRL-5872 cells.118 Cancer Cell 26, 106–120, July 14, 2014 ª2014 Elsevier Inc.After infection with the lentivirus or retrovirus, the infected CRL-5872 cells
were then selected and maintained in puromycin (2.5 mg/ml). CRL-5872
stable cell lines were trypsinized and counted. Dulbecco’s modified Eagle’s
medium (100 ml aliquots) containing 1 3 106 cells were mixed with Matrigel
(cell suspension:Matrigel of 1:1) and were implanted subcutaneously into
5-week-old female nude mice according to standard procedures (n = 6 mice
per group). Twenty-one days after injection, the mice were euthanized using
carbon dioxide and the tumor masses were isolated and weighed.
Autophagy Assay and Detection of Oxidatively Damaged Proteins
The formation of GFP-LC3 puncta, the level of lipidated LC3, level of oxida-
tively damaged proteins, the production of ROS, DNA damage, and the auto-
phagic turnover of p62 were assayed in CRL-5872 cells. CRL-5872 cells were
transfected with the genes of interest, and ROS production was detected
using the total ROS detection kit (ENZO ENZ-51011) as described in an earlier
study (Tarpey and Fridovich, 2001). Protein oxidation was determined using an
OxyBlot Protein Oxidation Detection Kit (Millipore), according to the manufac-
turer’s instruction.
OPTN-Knockout Mice and Animal Handling
The OPTN / mice were generated in the European Conditional Mouse
Mutagenesis Program (EUCOMM) (Skarnes et al., 2011) and distributed by
the University of Oulu, Finland. All animals were handled following the
protocols reviewed and approved by the Institutional Animal Care and Use
Committee (IACUC).
Clinical Specimens
The liver and stomach cancer tissues were collected from patients in Zhong-
shan Hospital, Medical College of Fudan University, Shanghai. The lung
cancer tissue microarrays (Number: HLug-NSCLC150PT-01), which con-
tained samples from 75 cases of human non-small-cell lung cancer (NSCLC)
in Taizhou Hospital (Zhejiang), were provided by Shanghai Outdo Biotech.
Informed consents were obtained from all subjects in accordance with the
protocol approved by the individual institutional Ethics Committees.
Isolation of Murine Peritoneal Macrophages
Murine peritoneal macrophageswere isolated as described in a previous study
(Zhang et al., 2008) with slight modifications.
Statistical Methods
Data were analyzed by using Prism 5 (GraphPad Software). An unpaired t test
was performed using GraphPad Prism version 5.00 for Windows, GraphPad
Software, San Diego, California, USA, http://www.graphpad.com. Results
are presented as means ± SEM.
Full methods and any associated references are available in the online
Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.ccr.2014.05.015.
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